⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6933560 | 0.85 | — | — | |
| SCHEMBL29114759 | 0.76 | — | — | |
| SCHEMBL34467252 | 0.72 | — | — | |
| SCHEMBL4791875 | 0.67 | — | — | |
| SCHEMBL9687572 | 0.67 | — | — | |
| SCHEMBL611093 | 0.67 | — | — | |
| SCHEMBL6668165 | 0.66 | — | — | |
| SCHEMBL6757994 | 0.65 | — | — | |
| SCHEMBL8002495 | 0.65 | — | — | |
| SCHEMBL17318048 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010014758-A1 | USE OF HYDROGENATED PYRIDO[4,3-B] INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS | EDISON PHARMACEUTICALS, INC. (US) | 2010-02-04 | — | — | WO | claimed |
| EP-1414819-B1 | THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES | PHARMACIA & UPJOHN CO LLC (US) | 2005-10-12 | — | — | EP | claimed |
| EP-1414819-A1 | THERAPEUTIC 1H-PYRIDO 4,3-b]INDOLES | PHARMACIA & UPJOHN COMPANY (US) | 2004-05-06 | — | — | EP | claimed |
| WO-2003014118-A1 | THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES | PHARMACIA & UPJOHN COMPANY (US) | 2003-02-20 | — | — | WO | claimed |
| EP-0876818-B1 | AGENT FOR TREATING NEURO-DEGENERATIVE DISORDERS | SELENA PHARMACEUTICALS INC (US) | 2002-12-18 | — | — | EP | claimed |
| JP-52036697-A | — | — | None | — | — | JP | disclosed |
| JP-52036696-A | — | — | None | — | — | JP | disclosed |
| JP-55154972-A | — | — | None | — | — | JP | disclosed |
| US-20250101022-A1 | PROCESS FOR PREPARING INTERMEDIATES FOR 1-(4-FLUOROPHENYL)-4-((6bR,10aS)-3-METHYL-2,3,6b,9,10,10a-HEXAHYDRO-1H-PYRIDO[3’,4’:4,5]PYRROLO[1,2,3-de]QUINOXALIN-8(7H)-YL)BUTAN-1-ONE | INTRA-CELLULAR THERAPIES, INC. (US) | 2025-03-27 | — | — | US | disclosed |
| US-12139490-B2 | Process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one | INTRA-CELLULAR THERAPIES, INC. (US) | 2024-11-12 | — | — | US | disclosed |
| US-20230404960-A1 | DISORDERS IMPLICATING PUFA OXIDATION | BIOJIVA LLC (US) | 2023-12-21 | — | — | US | disclosed |
| US-20220332716-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. (US) | 2022-10-20 | — | — | US | disclosed |
| EP-0876818-B1 | AGENT FOR TREATING NEURO-DEGENERATIVE DISORDERS | SELENA PHARMACEUTICALS INC (US) | 2002-12-18 | — | — | EP | disclosed |
| US-20020115682-A1 | Agents for treating neurodegenerative disorders | GRIGOR'EVA, I. V. (RU) | 2002-08-22 | — | — | US | disclosed |
| US-20010020028-A1 | Agents for treating neurodegenerative disorders | YUROVSKAYA, M. A. (RU) | 2001-09-06 | — | — | US | disclosed |
| US-6187785-B1 | ADMINISTERING HYDROGENATED PYRIDO(4,3-B)INDOLE DERIVATIVES SUCH AS DIMEBOLIN TO TREAT ALZHEIMER*S DISEASE | SELENA PHARMACEUTICALS, INC. | 2001-02-13 | — | — | US | disclosed |
| EP-0876818-A2 | AGENT FOR TREATING NEURO-DEGENERATIVE DISORDERS | Zefirov, Nikolai Serafimovich (RU) | 1998-11-11 | — | — | EP | disclosed |
| JP-S55154972-A | HEXAHYDRO-1H-PYRIDO 4,3-B INDOLE DERIVATIVE | DAINIPPON PHARMACEUT CO LTD | 1980-12-02 | — | — | JP | disclosed |
| JP-S5236697-A | PROCESS FOR PREPARATION OF HEXAHYDRO-1H- PYRIDO(4,3-B)-INDOLE DERIVATI VES | DAINIPPON PHARMACEUT CO LTD | 1977-03-22 | — | — | JP | disclosed |
| JP-S5236696-A | PROCESS FOR PREPARATION OF HEXAHYDRO-1H- PYRIDO(4,3-B)-INDOLES | DAINIPPON PHARMACEUT CO LTD | 1977-03-22 | — | — | JP | disclosed |